Sotrovimab para el tratamiento de pacientes con COVID-19
Sotrovimab para el tratamiento de pacientes con COVID-19
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1379533
Nirmatrelvir-ritonavir (Paxlovid) para el tratamiento de pacientes con COVID-19: [2 de julio de 2022]
Nirmatrelvir-ritonavir (Paxlovid) para el tratamiento de pacientes con COVID-19: [2 de julio de 2022]
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1379549
FDA Conducting Evaluation of Key Agency Activities to Strengthen Operations
FDA Conducting Evaluation of Key Agency Activities to Strengthen Operations
http://www.fda.gov/news-events/press-announcements/fda-conducting-evaluation-key-agency-activities-strengthen-operations
FDA Roundup: July 19, 2022
FDA Roundup: July 19, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-19-2022
MKS Enterprise LLC Voluntary Recalls of Dose Vital VIP Vital Honey Due to Presence of Undeclared Tadalafil
FDA Roundup: July 15, 2022
FDA Roundup: July 15, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-15-2022
For Monkeypox Testing, Use Lesion Swab Samples to Avoid False Results: FDA Safety Communication
Vi-Jon, LLC Expands Voluntary Nationwide Recall of Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor Due to Microbial Contamination
FDA Provides Educational Resources for Parents and Caregivers to Support Confidence for Imported Infant Formula Products
FDA Provides Educational Resources for Parents and Caregivers to Support Confidence for Imported Infant Formula Products
http://www.fda.gov/news-events/press-announcements/fda-provides-educational-resources-parents-and-caregivers-support-confidence-imported-infant-formula